The addition of TIGIT blockade to MWA resulted in the up-regulation of CXCL9 and CXCL10 expression in TAMs and their receptor CXCR3 expression in T cells, which restrain tumor growth and enhance anti-tumor immunity [25]. Here, CXCL10 is linked to neoplasm.